信铭生命科技集团有限公司（下称“信铭生命科技”，00474）于2025年12月1日公布截至2025年11月30日的股份变动月报表。该报告显示，公司本月无新增发行、购回或注销行为，股本维持稳定。
信铭生命科技注册股本维持在50,000,000,000股，面值每股0.01港元，总额为5亿港元；与上月底相比，注册股本并无任何变化。报告期内，公司已发行股份仍为7,381,776,805股，未有库藏股份，已发行股份总数保持不变。
公司月报中并未披露任何有关股份期权、购回股份、可换股票据或其他股权激励计划的变动信息。截至2025年11月底，公司整体股本结构仍然保持稳定。
信铭生命科技在报告中确认，公司所有相关股份发行、出售或转让等事项均符合香港联交所上市规则及相关法律法规，且已获得董事会授权批准。上述月报由公司秘书萧镇邦呈交。该公司表示，将继续按照相关法规披露最新股本及股份变动情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.